CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 2 filers reported holding CANCER GENETICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $0 | – | 454 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 454 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 454 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 454 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 454 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 454 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 454 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 454 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | -50.0% | 454 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 454 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | +100.0% | 454 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 454 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 454 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 454 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 454 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | -91.7% | 454 | -24.3% | 0.00% | – |
| Q3 2013 | $12,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 836,908 | $3,431,000 | 3.54% |
| Fairbanks Capital Management, Inc. | 233,170 | $956,000 | 0.94% |
| DIKER MANAGEMENT LLC | 63,315 | $260,000 | 0.12% |
| EAM Investors, LLC | 117,878 | $483,000 | 0.08% |
| WEDBUSH SECURITIES INC | 87,000 | $357,000 | 0.05% |
| Acrospire Investment Management LLC | 11,090 | $45,000 | 0.04% |
| TWO SIGMA SECURITIES, LLC | 16,053 | $66,000 | 0.01% |
| THOMPSON DAVIS & CO., INC. | 2,000 | $8,000 | 0.01% |
| Manchester Capital Management LLC | 9,000 | $37,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 40,158 | $165,000 | 0.00% |